Liselotte Nilsson
Sales & Marketing bij CLINICAL LASERTHERMIA SYSTEMS AB
Profiel
Liselotte Nilsson is currently the Vice President-Marketing at Clinical Laserthermia Systems AB since 2021.
Prior to this, she worked as the Head-Marketing at Phase Holographic Imaging AB, Marketing Manager at ProstaLund AB, and Marketing Manager at Svar Life Science AB.
Actieve functies van Liselotte Nilsson
Bedrijven | Functie | Begin |
---|---|---|
CLINICAL LASERTHERMIA SYSTEMS AB | Sales & Marketing | 01-01-2021 |
Eerdere bekende functies van Liselotte Nilsson
Bedrijven | Functie | Einde |
---|---|---|
PROSTALUND AB | Sales & Marketing | - |
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Sales & Marketing | - |
PHASE HOLOGRAPHIC IMAGING PHI AB | Sales & Marketing | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CLINICAL LASERTHERMIA SYSTEMS AB | Health Technology |
PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
PROSTALUND AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Commercial Services |